In a deal worth up to $1 billion, Ideaya Biosciences Inc. is in-licensing Jiangsu Hengrui Pharmaceuticals Co. Ltd.’s SHR-4849 ...
Among the most profound results presented at the 2024 European Society for Medical Oncology (ESMO) Congress were the 10-year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback